Preventive treatment reduces diabetic retinopathy complications
In a clinical trial, early treatment with anti-vascular endothelial growth factor (VEGF) injections slowed diabetic retinopathy, a complication of diabetes that causes damage to the blood vessels of the light-sensitive tissue in the retina. However, two years into the four-year study, the early treatment’s effect on vision – including changes in visual acuity and vision …